Matrix Metalloproteinase Responsive Nanoparticles for Synergistic Treatment of Colorectal Cancer via Simultaneous Anti-Angiogenesis and Chemotherapy. [electronic resource]
- Bioconjugate chemistry Dec 2016
- 2943-2953 p. digital
Publication Type: Journal Article
1520-4812
10.1021/acs.bioconjchem.6b00643 doi
Angiogenesis Inhibitors--pharmacology Animals Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics Camptothecin--administration & dosage Colorectal Neoplasms--drug therapy Drug Liberation HT29 Cells--drug effects Humans Male Matrix Metalloproteinase 2--metabolism Mice, Inbred BALB C Nanoparticles--administration & dosage Niacinamide--administration & dosage Phenylurea Compounds--administration & dosage Photoacoustic Techniques--methods Rats, Sprague-Dawley Sorafenib Tissue Distribution Tumor Microenvironment Xenograft Model Antitumor Assays